Key highlights Breakthrough Therapy Designation ensures that FDA will work closely with MAPS to complete Phase 3 trials as efficiently as possible MAPS and FDA have also reached agreement on design, primary …
PRESS RELEASE: Opportunities Expand for Psychedelic Cryptocurrency Philanthropy August 13 cruise on the San Francisco Bay to benefit MDMA-assisted psychotherapy for PTSD research CONTACT: Brad Burge, Director …
PRESS RELEASE: Zendo Project Launches $60,000 Campaign to Expand Festival Support Services Psychedelic harm reduction service brings peer counseling and professional trainings to more events this summer …
Observational research published in American Journal of Drug and Alcohol Abuse CONTACT:Brad Burge, Director of Communications and Marketing, MAPSMedia Requests:Press Resources: Ismail Ali, Policy Fellow, …
PRESS RELEASE: Dr. Bronner’s Pledges $5 Million to MAPS to Make MDMA into FDA-Approved Medicine to Treat PTSD CONTACT: Brad Burge, Director of Communications and Marketing, MAPS Media Requests: Press …
PRESS RELEASE: Statement on the Adequacy of Marijuana Provided by NIDA for Phase 2 Clinical Trials for PTSD in Veterans CONTACT: Brad Burge, MAPS Director of Communications and Marketing Media Requests: …
PRESS RELEASE: U.S. Sentencing Commission Reviews MDMA Guidelines for First Time in 16 Years Disparity between MDMA and marijuana sentencing is currently 500:1 Rick Doblin, MAPS Founder and Executive Director, …
PRESS RELEASE: Global Scientists Convene in California to Explore Breakthroughs in Psychedelic Science and Medicine Psychedelic Science 2017 to feature over 175 presenters at six-day gathering To celebrate …
CONTACT: Natalie Ginsberg, MAPS Policy and Advocacy Manager natalie@maps.org WASHINGTON, D.C.—The second annual Catharsis on the Mall, a free and radically inclusive 48-hour healing vigil based on the …
CONTACT: Brad Burge, MAPS Director of Communications and Marketing Media Requests: Press Resources: NEW YORK — On October 8, 2016, the Multidisciplinary Association for Psychedelic Studies (MAPS) will …
PRESS RELEASE AUGUST 11, 2016 CONTACT: Rick Doblin, Ph.D., MAPS Executive Director rick@maps.org 617-276-7806 Natalie Ginsberg, MAPS Policy & Advocacy Manager natalie@maps.org 917-520-5531 DEA Eliminates …
WASHINGTON, D.C. — Today, the Drug Enforcement Administration (DEA) announced their intention to grant licenses to additional marijuana growers for research, thereby ending the DEA-imposed 48-year monopoly …
